Search

everythinglearnresearchcommunity

for

Search:↓

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

Nizoral improved menstrual cycles and reduced hair growth in patients with hyperandrogenism.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Microagulhamento e intradermoterapia juntos melhoram o crescimento capilar em mulheres menopausadas.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Glucocorticoids can cause long-term loss of body hair by lowering adrenal androgens.

The patient's long-term symptoms were due to Sheehan's syndrome, which improved with hormone therapy.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

Hair loss in women in Lagos, Nigeria is not common, but when it happens, it's usually severe.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Viviscal may modestly improve hair loss in women without adverse effects.

Topical botanical lotion increases hair density and improves quality of life in women with hair loss.